MicuRx Pharmaceuticals Inc., a Union City, Calif.-based developer of anti-infective drugs, has raised $10 million in Series A funding from Morningside Group. www.micurx.com
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it's been delivered there.If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: email@example.com.
Copyright PEI Media
Not for publication, email or dissemination